help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Venihaki, M.
Right arrow Articles by Margioris, A. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Venihaki, M.
Right arrow Articles by Margioris, A. N.
Endocrinology Vol. 139, No. 2 713-722
Copyright © 1998 by The Endocrine Society


ARTICLES

KAT45, a Noradrenergic Human Pheochromocytoma Cell Line Producing Corticotropin-Releasing Hormone1

M. Venihaki2, K. Ain, E. Dermitzaki, A. Gravanis and A. N. Margioris

Departments of Clinical Chemistry (M.V., E.D., A.N.M.) and Pharmacology (A.G.), University of Crete School of Medicine, Crete, Greece; and the Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, University of Kentucky College of Medicine (K.A.), Lexington, Kentucky 40536-0084

Address all correspondence and requests for reprints to: Dr. Andrew N. Margioris, Department of Clinical Chemistry, University of Crete School of Medicine, Heraklion GR-711 10, Crete, Greece. E-mail: andym{at}med.uch.g

KAT45 cells were derived from a human pheochromocytoma, which also caused ectopic Cushing’s syndrome, and developed into a cell line spontaneously after the continuous primary culture of the tumor cells. These human pheochromocytoma cells were compared with the extensively characterized PC12 rat pheochromocytoma cell line. KAT45 cells resembled PC12 cells in morphology, proliferation rate, response to cholinergic stimuli, and the development of dendrite-like projections after exposure to nerve growth factor. They produced norepinephrine and epinephrine in a ratio of 50:1, as opposed to production of dopamine by PC12 cells, in amounts 1 order of magnitude higher compared with PC12. Because of the ectopic Cushing’s syndrome in our patient, her normal ACTH level, and the knowledge that PC12 cells and even normal rat chromaffin cells appear to produce CRH, we examined whether KAT45 cells also produced this neuropeptide. Indeed, KAT45 cells released authentic CRH and contained an apparently intact CRH transcript. Nicotine and KCl depolarization stimulated the secretion of CRH, whereas interleukin-1ß, glucocorticoids, and nerve growth factor stimulated its synthesis. In addition to the potential systemic effects of CRH, which in our patient produced ectopic Cushing’s syndrome, CRH can exert paracrine effects within normal or tumoral adrenals. We used KAT45 cells as a model for the study of the local role of CRH. CRH affected several parameters of KAT45 cell metabolism, including their proliferation rate, synthesis of catecholamines, and production of POMC-derived peptides. KAT45 cells, in addition to the data they provided regarding the in vitro profile of a human CRH-producing pheochromocytoma, may prove to be a valuable auxiliary to the PC12 cell line.




This article has been cited by other articles:


Home page
EndocrinologyHome page
E. Dermitzaki, C. Tsatsanis, V. Minas, E. Chatzaki, I. Charalampopoulos, M. Venihaki, A. Androulidaki, M. Lambropoulou, J. Spiess, E. Michalodimitrakis, et al.
Corticotropin-Releasing Factor (CRF) and the Urocortins Differentially Regulate Catecholamine Secretion in Human and Rat Adrenals, in a CRF Receptor Type-Specific Manner
Endocrinology, April 1, 2007; 148(4): 1524 - 1538.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Fukuda, K. Takahashi, T. Suzuki, M. Saruta, M. Watanabe, T. Nakata, and H. Sasano
Urocortin 1, Urocortin 3/Stresscopin, and Corticotropin-Releasing Factor Receptors in Human Adrenal and Its Disorders
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4671 - 4678.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Dermitzaki, C. Tsatsanis, A. Gravanis, and A. N. Margioris
Corticotropin-releasing Hormone Induces Fas Ligand Production and Apoptosis in PC12 Cells via Activation of p38 Mitogen-activated Protein Kinase
J. Biol. Chem., March 29, 2002; 277(14): 12280 - 12287.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. Dermitzaki, A. Gravanis, M. Venihaki, C. Stournaras, and A. N. Margioris
Opioids Suppress Basal and Nicotine-Induced Catecholamine Secretion Via a Stabilizing Effect on Actin Filaments
Endocrinology, May 1, 2001; 142(5): 2022 - 2031.
[Abstract] [Full Text]


Home page
Mol Hum ReprodHome page
A. Makrigiannakis, A.N. Margioris, E. Chatzaki, E. Zoumakis, G.P. Chrousos, and A. Gravanis
The decidualizing effect of progesterone may involve direct transcriptional activation of corticotrophin-releasing hormone from human endometrial stromal cells
Mol. Hum. Reprod., September 1, 1999; 5(9): 789 - 796.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society